51662-1337-3 : NDC 2026 Code

51662-1337-3 : Dobutamine ( Dobutamine )

Additionally :

You can get information about “51662-1337-3” NDC code in 51662-1337-3 in HTML format

HTML | 51662-1337-3 in TXT (Plain Text) format

TXT | 51662-1337-3 in PDF (Portable Document Format)

PDF | 51662-1337-3 in XML format

XML formats.

NDC Code : 51662-1337-3 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "51662-1337-3",
    "PackageDescription": "10 POUCH in 1 CASE (51662-1337-3)  / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1337-2)  / 20 mL in 1 VIAL, SINGLE-DOSE",
    "NDC11Code": "51662-1337-03",
    "ProductNDC": "51662-1337",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Dobutamine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Dobutamine",
    "DosageFormName": "INJECTION, SOLUTION, CONCENTRATE",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20181126",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA074086",
    "LabelerName": "HF Acquisition Co LLC, DBA HealthFirst",
    "SubstanceName": "DOBUTAMINE HYDROCHLORIDE",
    "StrengthNumber": "12.5",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2024-02-21",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20220612",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}